Evidence map›Paper›PMID 39000204›Full record

ArticleInternational journal of molecular sciences2024

Reducing FKBP51 Expression in the Ventral Hippocampus Decreases Auditory Fear Conditioning in Male Rats.

Nashaly Irizarry-Méndez, Marangelie Criado-Marrero, Anixa Hernandez, Maria Colón, James T Porter

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nashaly Irizarry-MéndezDepartment of Basic Sciences, Ponce Research Institute, Ponce Health Sciences University, Ponce 00716, Puerto Rico.ORCID 0000-0003-2809-5518
Marangelie Criado-MarreroDepartment of Neuroscience, University of Florida, Gainesville, FL 32610, USA.ORCID 0000-0001-8307-0183
Anixa HernandezDepartment of Basic Sciences, Ponce Research Institute, Ponce Health Sciences University, Ponce 00716, Puerto Rico.
Maria ColónDepartment of Basic Sciences, Ponce Research Institute, Ponce Health Sciences University, Ponce 00716, Puerto Rico.
James T PorterDepartment of Basic Sciences, Ponce Research Institute, Ponce Health Sciences University, Ponce 00716, Puerto Rico.ORCID 0000-0002-8122-6487

Funding

The Role of Midbrain to Prelimbic Cortex Glutamatergic projections in Stress-induced Drug SeekingU54MD007579 · NIMHD · PONCE SCHOOL OF MEDICINE · PI Emmanuel Antonio Cruz, Kenira J Thompson · 2019 to 2026
$35.9M
RISE Option III: Ponce School of Medicine MBRS-RISE ProgramR25GM082406 · NIGMS · PONCE SCHOOL OF MEDICINE · PI APPLEYARD, CAROLINE B · 2008 to 2021
$9.5M
UNIVERSITY OF PUERTO RICO PONCE RESEARCH INITIATIVE FOR SCIENTIFIC ENHANCEMENT: UR25GM096955 · NIGMS · UNIVERSITY OF PUERTO RICO PONCE · PI SUAREZ-MARTINEZ, EDU B · 2011 to 2020
$5.7M
G-RISE at Ponce Health Sciences UniversityT32GM144896 · NIGMS · PONCE SCHOOL OF MEDICINE · PI APPLEYARD, CAROLINE B · 2022 to 2024
$2.0M
Fear Modulation of IL excitabilityR15MH101700 · NIMH · PONCE SCHOOL OF MEDICINE · PI PORTER, JAMES T. · 2013 to 2013
$478k
Fkbp5 modulation of prefrontal function.R15MH116345 · NIMH · PONCE SCHOOL OF MEDICINE · PI PORTER, JAMES T. · 2018 to 2018
$470k
NIGMS NIH HHS 1R25GM082406-01NIGMS NIH HHS 1T32GM144896-01NIGMS NIH HHS R25 GM082406NIGMS NIH HHS R25 GM096955NIGMS NIH HHS T32 GM144896NIMHD NIH HHS 5U54MD007579NIMHD NIH HHS U54 MD007579NIMH NIH HHS 1R15MH116345NIMH NIH HHS R15 MH101700
6 · The paper itself

Abstract

Fear conditioning evokes a physiologic release of glucocorticoids that assists learning. As a cochaperone in the glucocorticoid receptor complex, FKBP51 modulates stress-induced glucocorticoid signaling and may influence conditioned fear responses. This study combines molecular and behavioral approaches to examine whether locally reducing FKBP51 expression in the ventral hippocampus is sufficient to affect fear-related behaviors. We hypothesized that reducing FKBP51 expression in the VH would increase glucocorticoid signaling to alter auditory fear conditioning. Adult male rats were injected with an adeno-associated virus (AAV) vector expressing short hairpin - RNAs (shRNA) targeting FKBP5 into the ventral hippocampus to reduce FKBP5 levels or a control AAV. Infusion of FKBP5-shRNA into the ventral hippocampus decreased auditory fear acquisition and recall. Although animals injected with FKBP5-shRNA showed less freezing during extinction recall, the difference was due to a reduced fear recall rather than improved extinction. Reducing ventral hippocampus FKBP51 did not affect exploratory behavior in either the open field test or the elevated zero maze test but did increase passive behavior in the forced swim test, suggesting that the reduction in auditory fear recall was not due to more active responses to acute stress. Furthermore, lower ventral hippocampus FKBP51 levels did not alter corticosterone release in response to restraint stress, suggesting that the reduced fear recall was not due to lower corticosterone release. Our findings suggest FKBP51 in the ventral hippocampus plays a selective role in modulating fear-learning processes and passive behavioral responses to acute stress rather than hypothalamic-pituitary-adrenal axis reactivity or exploratory responses.

Indexed as

FearHippocampusTacrolimus Binding ProteinsAnimalsCorticosteroneExtinction, PsychologicalMaleRatsRats, Sprague-DawleyReceptors, GlucocorticoidRNA, Small InterferingTacrolimus Binding Protein 5CorticosteroneReceptors, GlucocorticoidRNA, Small InterferingTacrolimus Binding Protein 5Tacrolimus Binding Proteinsfear conditioningfear extinctionFKBP5glucocorticoidsstressventral hippocampus

Identifiers

PMID39000204
PMCPMC11241630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.